Cellectar Biosciences Statistics

Total Valuation

CLRB has a market cap or net worth of $75.28 million. The enterprise value is $50.73 million.

Market Cap	75.28M
Enterprise Value	50.73M

Important Dates

The next estimated earnings date is Monday, November 4, 2024, before market open.

Earnings Date	Nov 4, 2024
Ex-Dividend Date	n/a

Share Statistics

CLRB has 35.85 million shares outstanding. The number of shares has increased by 100.67% in one year.

Shares Outstanding	35.85M
Shares Change (YoY)	+100.67%
Shares Change (QoQ)	+94.94%
Owned by Insiders (%)	3.20%
Owned by Institutions (%)	13.64%
Float	26.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	7.44
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.54, with a Debt / Equity ratio of 0.02.

Current Ratio	2.54
Quick Ratio	2.46
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -304.38% and return on invested capital (ROIC) is -152.45%.

Return on Equity (ROE)	-304.38%
Return on Assets (ROA)	-91.47%
Return on Capital (ROIC)	-152.45%
Revenue Per Employee	n/a
Profits Per Employee	-$2.55M
Employee Count	20
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-60,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.07% in the last 52 weeks. The beta is 0.99, so CLRB's price volatility has been similar to the market average.

Beta (5Y)	0.99
52-Week Price Change	-21.07%
50-Day Moving Average	2.10
200-Day Moving Average	2.91
Relative Strength Index (RSI)	47.15
Average Volume (20 Days)	211,306

Short Selling Information

The latest short interest is 2.20 million, so 6.15% of the outstanding shares have been sold short.

Short Interest	2.20M
Short Previous Month	1.62M
Short % of Shares Out	6.15%
Short % of Float	8.42%
Short Ratio (days to cover)	9.23

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-42.26M
Pretax Income	-51.04M
Net Income	-50.98M
EBITDA	-42.02M
EBIT	-42.26M
Earnings Per Share (EPS)	-$3.05

Full Income Statement

Balance Sheet

The company has $40.03 million in cash and $548,343 in debt, giving a net cash position of $39.48 million or $1.10 per share.

Cash & Cash Equivalents	40.03M
Total Debt	548,343
Net Cash	39.48M
Net Cash Per Share	$1.10
Equity (Book Value)	26.17M
Book Value Per Share	0.27
Working Capital	25.10M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$38.55 million and capital expenditures -$885,671, giving a free cash flow of -$39.44 million.

Operating Cash Flow	-38.55M
Capital Expenditures	-885,671
Free Cash Flow	-39.44M
FCF Per Share	-$1.10

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CLRB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-100.67%
Shareholder Yield	-100.67%
Earnings Yield	-69.72%
FCF Yield	-53.93%

Analyst Forecast

The average price target for CLRB is $21.00, which is 900.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$21.00
Price Target Difference	900.00%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on July 22, 2022. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Jul 22, 2022
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2